US Bancorp’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

US Bancorp’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,686	Closed	-$639K	–	3958
2020 Q3	$639K	Buy	4,686 +4,291	+1,086%	+$456K	﹤0.01%	1199
2020 Q2	$38K	Buy	+395	New	+$33K	﹤0.01%	2536
2020 Q1	–	Sell	-15	Closed	-$1K	–	3882
2019 Q4	$1K	Buy	+15	New	+$910	﹤0.01%	3625

US Bancorp's MYOK Position: Q4 2020 in Review

US Bancorp sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,686 shares — an estimated $639K sold.

US Bancorp first reported a position in MYOK in Q4 2019 and held it in 3 quarters. The position peaked at $639K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

US Bancorp reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
US Bancorp sold 4,686 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $639K.
US Bancorp first reported a position in MyoKardia, Inc. Common Stock in Q4 2019 and held it in 3 quarters.
US Bancorp's MyoKardia, Inc. Common Stock position peaked at $639K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on US Bancorp's 13F filing for Q4 2020, filed 4 Feb 2021.